SCHEMBL8778306

SCHEMBL8778306

Clc1ccc(Cc2cccc(-c3ncc4ccccc4n3)n2)c(Cl)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.46
LMNA P02545 4/20 0.46
HTT P42858 4/20 0.46
MAPT P10636 3/20 0.46
L3MBTL1 Q9Y468 3/20 0.46
TDP1 Q9NUW8 2/20 0.46
NPC1 O15118 1/20 0.46
PPP1CA P62136 1/20 0.46
CYP1A2 P05177 4/20 0.40
CYP2C9 P11712 3/20 0.40
PTGER1 P34995 3/20 0.40
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C19 P33261 1/20 0.39
GPR39 O43194 1/20 0.37
SLC9A1 P19634 1/20 0.36
KDM4E B2RXH2 2/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
VDR P11473 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8777799 0.90 PTGER1 (0.39) SMN1; SMN2LMNAHTTMAPTL3MBTL1
SCHEMBL8778175 0.90 PTGER1 (0.41) SMN1; SMN2LMNAHTTMAPTL3MBTL1
SCHEMBL3787471 0.89 CYP1A2 (0.37) SMN1; SMN2LMNAHTTMAPTL3MBTL1
SCHEMBL8777914 0.84 KDM4E (0.39) MAPTCYP1A2KDM4EMEN1KMT2A
SCHEMBL8778144 0.84 USP1 (0.39) SMN1; SMN2LMNAHTTMAPTL3MBTL1
SCHEMBL8777743 0.82 CYP1A2 (0.38) SMN1; SMN2LMNAHTTMAPTL3MBTL1
SCHEMBL8778052 0.82 S1PR3 (0.37) SMN1; SMN2HTTL3MBTL1TDP1NPC1
SCHEMBL8778228 0.81 S1PR3 (0.35) NPC1CYP1A2CYP2C9PTGER1CYP2C19
SCHEMBL8778217 0.81 USP1 (0.41) LMNATDP1NPC1CYP1A2CYP2D6
SCHEMBL13063656 0.80 CYP1A2 (0.34) SMN1; SMN2CYP1A2CYP2C9PTGER1CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120129875-A1 SUBSTITUTED QUINAZOLINES AS FUNGICIDES SYNGENTA CROP PROTECTION, LLC (US) 2012-05-24 US disclosed
US-20120129875-A1 SUBSTITUTED QUINAZOLINES AS FUNGICIDES SYNGENTA CROP PROTECTION, LLC (US) 2012-05-24 US disclosed
WO-2010136475-A1 SUBSTITUTED QUINAZOLINES AS FUNGICIDES SYNGENTA PARTICIPATIONS AG (CH) 2010-12-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120129875-A1 SUBSTITUTED QUINAZOLINES AS FUNGICIDES NAT1, NQO2, NOX1 SMN1; SMN2 3646/4885LMNA 3612/4885HTT 2814/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.